Leukemia, Myelodysplasia, Transplantation


CAR T-cell studies to be presented at ASH

Several studies set to be presented at the 2018 ASH Annual Meeting provide new insights regarding chimeric antigen receptor (CAR) T-cell therapies...


FDA approves glasdegib for AML

The U.S. Food and Drug Administration has approved the hedgehog pathway inhibitor glasdegib (Daurismo) for use in combination with low-dose...


CHMP backs blinatumomab for MRD

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended expanding marketing authorization for...